TLR9 and MyD88 are crucial for the maturation and activation of dendritic cells by paromomycin-miltefosine combination therapy in visceral leishmaniasis-Reference-Cited by-同舟云学术

TLR9 and MyD88 are crucial for the maturation and activation of dendritic cells by paromomycin-miltefosine combination therapy in visceral leishmaniasis

Published:2014-02-27 Issue:5 Volume:171 Page:1260-1274
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Das Sushmita¹,Rani Mukta²,Rabidas Vidyanand³,Pandey Krishna³,Sahoo Ganesh Chandra²,Das Pradeep¹³

Affiliation:

1. Department of Molecular Parasitology; Rajendra Memorial Research Institute of Medical Sciences; Indian Council of Medical Research; Bihar India

2. Department of Bioinformatics; Rajendra Memorial Research Institute of Medical Sciences; Indian Council of Medical Research; Bihar India

3. Department of Clinical Medicine; Rajendra Memorial Research Institute of Medical Sciences; Indian Council of Medical Research; Bihar India

Funder

Indian Council of Medical Research

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bph.12530/fullpdf

Reference43 articles.

1. TLR9-dependent activation of dendritic cells by DNA from Leishmania major favors Th1 cell development and the resolution of lesions;Abou Fakher;J Immunol,2009

2. Dendritic cells and the control of immunity;Banchereau;Nature,1998

3. Immunobiology of dendritic cells;Banchereau;Annu Rev Immunol,2000

4. Liposomal amphotericin B activates antifungal resistance with reduced toxicity by diverting Toll-like receptor signaling from TLR-2 to TLR-4;Bellocchio;J Antimicrob Chemother,2005

5. Liposomal amphotericin B for the treatment of visceral leishmaniasis;Bern;Clin Infect Dis,2006

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unmasking the Mechanism behind Miltefosine: Revealing the Disruption of Intracellular Ca2+ Homeostasis as a Rational Therapeutic Target in Leishmaniasis and Chagas Disease;Biomolecules;2024-03-27

2. TLR4 and TLR9 polymorphism: Probable role in susceptibility among the population of Bihar for Indian visceral leishmaniasis;Innate Immunity;2021-04-28

3. The anti‐parasitic drug miltefosine suppresses activation of human eosinophils and ameliorates allergic inflammation in mice;British Journal of Pharmacology;2021-02-02

4. Reciprocal changes in CD11c+CD11b+ and CD11c+CD8α+ dendritic cell subsets determine protective or permissive immune response in murine experimental VL;Vaccine;2020-01

5. Systematic Review of Host-Mediated Activity of Miltefosine in Leishmaniasis through Immunomodulation;Antimicrobial Agents and Chemotherapy;2019-07